Directs the commissioner of health to establish guidelines for onsite opioid overdose response capacity in community centers; defines "community center".
Directs the commissioner of the office of alcoholism and substance abuse services to collect data on the number of facilities sited and operating within each jurisdiction of each community board; make such data available on the office's website, updated as needed to maintain an accurate dataset; and consider such data in the course of the approval of the establishment, incorporation and certification of providers of substance use disorder services.
Establishes an intensive addiction and medical services integrated services pilot program to support two three-year demonstration programs that provide intensive addiction and medical services integrated services to individuals who have significant addiction and medical issues.
Includes xylazine and other substances in the definition of drug adulterant testing supplies for the purposes of the dispensing of such supplies by health care professionals or pharmacists to any person.
Includes xylazine and other substances in the definition of drug adulterant testing supplies for the purposes of the dispensing of such supplies by health care professionals or pharmacists to any person.
Relates to requirements for certain providers of services to be authorized to administer and dispense methadone or other controlled substances, including the establishment of a community advisory board.
Directs the commissioner of the department of health to promulgate rules and regulations promoting recovery from opioid misuse and reducing diversion of addiction medicines.
Requires health care professionals to prescribe opioid antagonists when prescribing an opioid and discuss the dangers of opioid addiction with such patient in a manner consistent with regulations promulgated by the commissioner of health.
Relates to the construction of facilities for chemical dependence services that promote the privacy of individuals while bathing, sleeping, using restrooms and receiving individual counseling services, while also allowing for maximization of the use of such facility.
Includes masking products including but not limited to synthetic urine, human urine, a substance used or designed to be added to human urine or a substance used or designed to be added to a chemical test, within the definition of drug-related paraphernalia.